Tag: Clovis Oncology

Innovation, Med Tech

Clovis Oncology spikes 15% after cancer drug receives early FDA approval

December 20, 2016


Shares of Clovis Oncology closed up 8.82 percent Monday as the company received early approval for its advanced ovarian cancer drug Rubraca (rucaparib). The stock was initially up 15 percent to $42.86 before being halted for volatility. After reopening, it […]